Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Journal of Cancer Survivorship : Research and Practice
|
August 7, 2025
Developing critical thinking and decision-making skills for cancer information: the Informed Health Choice-Cancer online learning resource
Mengqi Li, Declan Devane, Claire Beecher, et al.
HRB Open Research
|
September 27, 2023
Prioritising Informed Health Choices Key Concepts for those impacted by cancer: a protocol
Mengqi Li, Declan Devane, Claire Beecher, et al.
Irish Journal of Medical Science
|
March 21, 2025
An analysis of compassionate access programmes for novel oncology drugs
Sarah A Kelly, Karine E Ronan, Mohammed Zameer, et al.
La Radiologia Medica
|
December 10, 2024
Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapy
Laetitia Saccenti, Nicole Varble, Tabea Borde, et al.
Cancer Immunology, Immunotherapy : CII
|
January 29, 2019
The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma
David Agdashian, Mei ElGindi, Changqing Xie, et al.
Clinical and Translational Science
|
April 3, 2021
A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype
Marina Baretti, Enusha Karunasena, Marianna Zahurak, et al.
Clinical Colorectal Cancer
|
July 29, 2019
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer
Charalampos S Floudas, Gagandeep Brar, Donna Mabry-Hrones, et al.
The Oncologist
|
March 11, 2022
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma
Cecilia Monge, Erica C Pehrsson, Changqing Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2011
Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer
Athanassios Argiris, Austin G Duffy, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2020
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Changqing Xie, Austin G Duffy, Gagandeep Brar, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Journal of Cancer Survivorship : Research and Practice
|
August 7, 2025
Developing critical thinking and decision-making skills for cancer information: the Informed Health Choice-Cancer online learning resource
Mengqi Li, Declan Devane, Claire Beecher, et al.
HRB Open Research
|
September 27, 2023
Prioritising Informed Health Choices Key Concepts for those impacted by cancer: a protocol
Mengqi Li, Declan Devane, Claire Beecher, et al.
Irish Journal of Medical Science
|
March 21, 2025
An analysis of compassionate access programmes for novel oncology drugs
Sarah A Kelly, Karine E Ronan, Mohammed Zameer, et al.
La Radiologia Medica
|
December 10, 2024
Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapy
Laetitia Saccenti, Nicole Varble, Tabea Borde, et al.
Cancer Immunology, Immunotherapy : CII
|
January 29, 2019
The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma
David Agdashian, Mei ElGindi, Changqing Xie, et al.
Clinical and Translational Science
|
April 3, 2021
A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype
Marina Baretti, Enusha Karunasena, Marianna Zahurak, et al.
Clinical Colorectal Cancer
|
July 29, 2019
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer
Charalampos S Floudas, Gagandeep Brar, Donna Mabry-Hrones, et al.
The Oncologist
|
March 11, 2022
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma
Cecilia Monge, Erica C Pehrsson, Changqing Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2011
Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer
Athanassios Argiris, Austin G Duffy, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2020
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Changqing Xie, Austin G Duffy, Gagandeep Brar, et al.
Page
of 4